AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 60 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.87 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $30,000 | -98.3% | 13,660 | -95.6% | 0.00% | -92.0% |
| Q4 2019 | $1,813,000 | +688.3% | 311,539 | +330.9% | 0.05% | +733.3% |
| Q3 2019 | $230,000 | +132.3% | 72,296 | +205.7% | 0.01% | +200.0% |
| Q2 2019 | $99,000 | -39.6% | 23,649 | -0.4% | 0.00% | -50.0% |
| Q1 2019 | $164,000 | -33.1% | 23,735 | -39.1% | 0.00% | -33.3% |
| Q4 2018 | $245,000 | -70.0% | 38,966 | -17.0% | 0.01% | -64.7% |
| Q3 2018 | $816,000 | – | 46,923 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |